Kimourtzis, Georgios
Rangwani, Natasha
Jenkins, Bethan J.
Jani, Siddharth
McNaughton, Peter A.
Raouf, Ramin
Funding for this research was provided by:
Foundation for Education and European Culture (IPEP)
KMRT Joint Research Committee
Article History
Received: 13 March 2024
Accepted: 16 July 2024
First Online: 29 July 2024
Competing interests
: R.R. is involved in a research collaboration with GrĂ¼nenthal GmbH to develop microfluidic culture models based on human iPSCs for pain research. P.A.M. is involved in a drug discovery program in collaboration with Merck & Co, Inc, to develop HCN2-selective molecules as novel analgesics. G.K., N.R., B.J.J., and S.J. declare no competing interests.